Our Expertise

Transforming healthcare to meet today’s unprecedented challenges requires an acceleration in the adoption of innovation and the formation of partnerships across disciplines.

Newmarket Strategy applies deep regulatory, policy and market entry expertise to drive uptake of health innovations that have the ability to improve healthcare and transform lives.

We support companies as they navigate the major regulatory and policy challenges of healthcare delivery

Innovation and
Market Entry

We help clients navigate the complex commissioning and procurement landscape to achieve market entry, reimbursement and uptake.

Assessing and demonstrating the value that healthcare, life science and healthtech assets can provide at all stages of their life-cycle.
Providing strategic market access advice – including planning, sequencing, evidence generation and stakeholder management – to support companies through NICE, NCPE, SMC or ICER assessments.
Delivering tactical HTA support and project management, including training.
Navigating procurement pathways, defining new commercial propositions, and helping companies demonstrate value.

Regulatory and
policy analysis

We help clients understand value assessment systems, and provide insight on current policy and future regulatory developments.

Mobilising research to demonstrate the value proposition of health innovations.
Supporting regulatory approval for products and services through clinical evidence, HTA, health economic and other analysis.
Providing in-depth insight on developments in technical regulation and clinical protocols.
Understanding the commercial and other implications of the broader public policy environment.
Offering counsel to senior leaders on all aspects of the regulatory challenge, including crisis management advice and hands-on support to tackle regulatory issues.

Strategic partnerships

We help clients build partnerships within health systems, and work with investors, companies and other partners to unlock new commercial relationships or acquisitions.

Carrying out sectoral, commercial and market-scoping analysis for organisations considering bringing or growing their health innovations in priority markets.
Facilitating major commercial, clinical and research partnerships that deliver a ‘triple win’ for patients, clinicians and providers.
Finding suitable partners across the health ecosystem to enable innovators to scale up their products and services.
Sourcing opportunities for the investment community, and supporting M&A with competitor analysis, due diligence and other transaction services.

Strategic Government Affairs
for the health and life
sciences sector

We combine in-depth government, policy, and subject-matter expertise to support health and life sciences clients to effectively engage with senior decision-makers in government, the NHS and the wider sector. Our services are designed to enhance the adoption of transformative health innovations, with a clear focus on:

- Policy and Sector Analysis: Offering comprehensive insights into the implications of existing, upcoming, and potential future policies on client operations within the healthcare and life sciences sector.
- Value Proposition Development: Crafting persuasive value narratives for life sciences, pharma, and medtech clients, underscored by rigorous validation of key messages through consultations with industry and policy experts.
- Stakeholder Strategy and Engagement: Delivering tailored strategies for engaging with key opinion leaders and decision-makers in the health and life sciences sector, to help our clients introduce and spread their groundbreaking innovations within the UK life sciences market.
- Thought Leadership in Government Affairs: Creating impactful white papers, generating compelling evidence, and formulating strategic recommendations to influence government policy, to elevate our clients’ visibility and enhance patient access to novel treatments and technologies.

Learn more about our team

Our People